Tri-POC Tenofovir Dimer is primarily used in the development of prodrugs for antiviral therapies. It serves as a key intermediate in the synthesis of tenofovir-based compounds, which are widely utilized in the treatment of HIV and hepatitis B infections. The compound is designed to enhance the bioavailability and cellular uptake of the active drug, allowing for more efficient delivery and reduced dosing frequency. Its application is crucial in improving the pharmacokinetic properties of antiviral medications, making them more effective and patient-friendly. Additionally, it is explored in research for potential use in other viral infections, contributing to advancements in antiviral drug development.